latest guidelines on anti-cgrp antibodies: first-line and long-term use
Published 2 years ago • 226 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
4:05
for or against? anti-cgrp monoclonal antibodies as a first-line therapy for migraines
-
4:44
the updated guidelines for treating migraines with cgrp-targeted monoclonal antibodies
-
8:29
real-world data on anti-cgrp monoclonal antibodies
-
2:00
discontinuation of anti-cgrp antibodies in non-responders
-
1:26
update on ehf guideline for anti-cgrp antibodies for migraine prevention
-
1:47
anti-cgrp monoclonal antibodies for difficult to treat migraines: deliver trial
-
1:47
approval of anti-cgrp monoclonal antibodies for migraine in japan
-
2:09
blocking cgrp in migraine patients: cardiovascular implications
-
1:30
preliminary data on the use of anti-cgrp mabs in pediatric migraine
-
4:58
combination treatment with cgrp mabs and onabotulinumtoxina for chronic migraine control
-
20:54
cgrp monoclonal antibodies & migraine management during covid-19 pandemic
-
18:18
migraine prevention in the real world: exploring the role of anti-cgrp antibodies
-
43:01
case conversations and expert perspectives in the use of anti-cgrp antibody therapies in migraine
-
5:33
real-world studies of cgrp monoclonal antibodies and gepants for migraine
-
3:19
real-world studies show effectiveness of anti-cgrp mabs in difficult to treat patients with migraine
-
2:52
fremanezumab in patients with chronic or episodic migraine
-
22:19
adverse events of anti-cgrp monoclonal antibodies for migraine - migraine masterclass: webinar 6
-
0:47
the future of oral-cgrp drugs in migraine prevention
-
16:21
the latest data on combining botox with anti-cgrp medications